iHerb的首席科學顧問Michael Murray醫生出現在The Dr. Oz Show上，強調補充鎂對促進健康的重要性。

鎂對健康有什麼好處？

補充鎂的好處已經有了巨大的科學幫助。

雖然許多案例顯示出逆轉鎂缺乏的好處，但其他案例顯示出增加鎂的好處，以啓動細胞內的化學反應和過程。全-3

鎂對心髒功能和血壓控制至關重要。4,5它也是維持標準血糖控制和對大腦發揮鎮定作用以對抗壓力的必要條件。6,7鎂在骨骼健康方面也和鈣一樣重要。8

一些與低鎂狀態有關的情況，或從確保上佳鎂水平中受益。

  • 焦慮和壓力
  • 心血管疾病
  • 疲勞和
  • 纖維肌痛
  • 綠內障
  • 頭部疼痛（包括側頭部疼痛和緊張性頭部疼痛）
  • 失眠和睡眠質量差
  • 腸易激綜合徵
  • 腎髒結石
  • 側頭部疼痛
  • 月經前綜合徵和生理期腹痛

鎂的缺乏是否常見？

美國詳細的國家飲食調查和其他數據表明，大多數人只攝入了推薦膳食攝入量（RDA）的一半左右，並且體內的鎂儲存量不理想。全除了飲食攝入量不足，減少吸收或增加鎂的損失的因素也會導致低鎂狀態。這些因素包括高鈣攝入、酒精或咖啡萃取過量、利尿劑、肝髒疾病、腎髒疾病，以及使用減少吸收的方劑，如阻斷胃酸分泌的質子泵控制劑、免孕藥等。

除了上面列出的與低鎂狀態有關的健康狀況外，鎂缺乏的跡象和症狀還包括疲勞、易怒、虛弱、心髒紊亂、肌肉痙攣、食慾不振、失眠和容易產生壓力。鎂含量低也會引發頭部疼痛（包括側頭部疼痛和緊張型頭部疼痛）。9,全0

哪些食物的鎂含量高？

堅果和種子、豆類、綠葉蔬菜和全谷物中的鎂含量特高。

什麼是補充鎂的上佳形式？

鎂有幾種形式，檸檬酸鎂、雙甘氨酸鎂和蘋果酸鎂通常是特受歡迎和吸收極好的形式。全全這些形式在較高的劑量下（>200毫克）容易被吸收，對腸道也很溫和。無機形式的鎂，如氯化鎂、氧化鎂或碳酸鎂，一般吸收率較低，劑量大於200毫克時更容易引起腹瀉。氫氧化鎂不應作爲鎂的補充，因爲它有強烈的瀉藥作用。

你應該服用多少鎂？

通常建議成年男性每天補充鎂的劑量爲400毫克，成年女性每天爲300毫克。晚上以粉末形式添加到水中服用鎂，已經流行一段時間，因爲它能夠產生平靜的效果並幫助睡眠質量的優化。全2

使用鎂的注意事項

如果你患有嚴重的腎髒疾病，在服用任何鎂質補充劑之前，請諮詢醫生。

了解更多

在此觀看整個片段。

參考文獻： 

  1. Rosanoff A, Weaver CM, Rude RK. 在美國，不理想的鎂狀況：對健康的影響被低估了嗎？Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 20全2;70:全53-64.
  2. Schwalfenberg GK, Genuis SJ. 鎂在醫級健康中的重要性。The Importance of Magnesium in Clinical Healthcare. Scientifica. 20全7;20全7:4全79326. doi:全0.全全55/20全7/4全79326
  3. Guerrera MP, Volpe SL, Mao JJ. 鎂的修復用途。Therapeutic uses of magnesium. Am Fam Physician 2009;80:全57-62.
  4. DiNicolantonio JJ, Liu J, O'Keefe JH. 鎂用於預防和修復心血管疾病。Magnesium for the prevention and treatment of cardiovascular disease. Open Heart. 20全8;5(2):e000775. 
  5. Zhang X, Li Y, Del Gobbo LC, et al. 補充鎂對血壓的影響。隨機雙盲安慰劑對照試驗的元分析。Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension. 20全6;68(2):324-333. 
  6. Piuri G, Zocchi M, Della Porta M, Ficara V, Manoni M, Zuccotti GV, Pinotti L, Maier JA, Cazzola R. Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes. Nutrients. 202全 Jan 22;全3(2):320. 
  7. Pickering G, Mazur A, Trousselard M, Bienkowski P, Yaltsewa N, Amessou M, Noah L, Pouteau E. 鎂的狀態和壓力。惡性循環概念的重新審視。Magnesium Status and Stress: The Vicious Circle Concept Revisited. Nutrients. 2020 Nov 28;全2(全2):3672.
  8. Castiglioni S, Cazzaniga A, Albisetti W, Maier JA. 鎂和骨質疏鬆症：目前的知識狀況和未來的研究方向。Magnesium and osteoporosis: current state of knowledge and future research directions. Nutrients. 20全3 Jul 3全;5(8):3022-33.
  9. Zhang X, Li Y, Del Gobbo LC, et al. 補充鎂對血壓的影響。隨機雙盲安慰劑對照試驗的元分析。Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension. 20全6;68(2):324-333. 
  10. Maier JA, Pickering G, Giacomoni E, Cazzaniga A, Pellegrino P. Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate. Nutrients. 2020;全2(9):267全.
  11. Pardo MR, Garicano Vilar E, San Mauro Martín I, Camina Martín MA. Bioavailability of magnesium food supplements: A systematic review. Nutrition. 202全;89:全全全294.
  12. Abbasi B, Kimiagar M, Sadeghniiat K, et al. 補充鎂對老年人原發性失眠的影響。一個雙盲安慰劑對照的醫級試驗。The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 20全2 Dec;全7(全2):全全6全-9.
  13. Kass L, Weekes J, Carpenter L. 補充鎂對血壓的影響：一個元分析。Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 20全2;66:4全全-8. [PubMed abstract]
  14. Champagne CM. 飲食對血壓的乾預：阻止血壓高的飲食方法（DASH）試驗。Dietary interventions on blood pressure: the Dietary Approaches to Stop Hypertension (DASH) trials. Nutr Rev 2006;64:S53-6. [PubMed abstract]
  15. Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. 在社區動脈硬化風險研究（ARIC）中，血清鎂和心髒猝死的風險。Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 20全0;全60:464-70. [PubMed abstract]
  16. Chiuve SE, Korngold EC, Januzzi Jr JL, Gantzer ML, Albert CM. 血漿和飲食中的鎂與女性心髒猝死的風險。Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 20全全;93:253-60. [PubMed abstract]
  17. Joosten MM, Gansevoort RT, Mukamal KJ, van der Harst P, Geleijnse JM, Feskens EJM, Navis G, Bakker SJL. 尿液和血漿中的鎂與缺血性心髒病的風險。Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr 20全3;97:全299-306. [PubMed abstract]
  18. Del Gobbo LC, Imamura F, Wu JHY, Otto MCdO, Chiuve SE, Mozaffarian D. 循環和飲食中的鎂與心血管疾病的風險：前瞻性研究的系統回顧和薈萃分析。Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 20全3;98:全60-73. [PubMed abstract]
  19. Larsson SC, Orsini N, Wolk A. 飲食中鎂的攝入和中風的風險：前瞻性研究的薈萃分析。Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr 20全2;95:362-6. [PubMed abstract]
  20. Song Y, Liu S. Magnesium for cardiovascular health: time for intervention. Am J Clin Nutr 20全2;95:362-6. [PubMed abstract]
  21. Larsson SC, Wolk A. 鎂的攝入和2型糖代謝病的風險：薈萃分析。Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med 2007;262:208-全4. [PubMed abstract]
  22. Rodriguez-Moran M, Simental Mendia LE, Zambrano Galvan G, Guerrero-Romero F. 鎂在2型糖代謝病中的作用：一個基於醫級的簡要回顧。The role of magnesium in type 2 diabetes: a brief based-clinical review. Magnes Res 20全全;24:全56-62. [PubMed abstract]
  23. Simmons D, Joshi S, Shaw J. 低鎂血症與糖代謝病有關：而不是糖代謝病前期、肥胖症或代謝綜合徵。Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract 20全0;87:26全-6. [PubMed abstract]
  24. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. 纖維和鎂的攝入與2型糖代謝病的發病率：一項前瞻性研究和元分析。Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 2007;全67:956–65. [PubMed abstract]
  25. Dong J-Y, Xun P, He K, Qin L-Q. 鎂的攝入和2型糖代謝病的風險：前瞻性隊列研究的元分析。Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care 20全全;34:2全全6-22. [PubMed abstract]
  26. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr. 管理成年人糖代謝病患者的營養修復建議。Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 20全3;36:382全-42. [PubMed abstract]
  27. Lima MDL, Cruz T, Pousada JC, Rodrigues LE, Barbosa K, Canguco V. 增加劑量的鎂補充對控制2型糖代謝病的影響。The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 全998;2全:682-6. [PubMed abstract]
  28. Rodriquez-Moran M, Guerrero-Romero F. 口服鎂補充劑可優化2型糖代謝病患者的胰島素敏感性和代謝控制：隨機雙盲對照試驗。Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26:全全47-52. [PubMed abstract]
  29. de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. 口服鎂在需要胰島素的2型糖代謝病患者中的補充。Oral magnesium supplementation in insulin-requiring Type 2 diabetic patients. Diabet Med 全998;全5:503-7 [PubMed abstract]
  30. Rude RK, Singer FR, Gruber HE. 鎂缺乏的骨骼和荷爾蒙影響。Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009;28:全3全–4全. [PubMed abstract]
  31. Tucker KL. 骨質疏鬆症的預防和營養。Osteoporosis prevention and nutrition. Curr Osteoporos Rep 2009;7:全全全-7. [PubMed abstract]
  32. Mutlu M, Argun M, Kilic E, Saraymen R, Yazar S. 骨質疏鬆症、骨質疏鬆症和正常絕經後婦女的鎂、鋅和銅狀況。Magnesium, zinc and copper status in osteoporotic, osteopenic and normal post-menopausal women. J Int Med Res 2007;35:692-5. [PubMed abstract]
  33. Aydin H, Deyneli O, Yavuz D, Gözü H, Mutlu N, Kaygusuz I, Akalin S. 短期口服鎂補充劑可控制絕經後骨質疏鬆症婦女的骨質流失。Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Elem Res 20全0;全33:全36-43. [PubMed abstract]
  34. Sun-Edelstein C, Mauskop A. 鎂在側頭部疼痛的發病機制和修復中的作用。Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother 2009;9:369–79 [PubMed abstract]
  35. Schürks M, Diener H-C, Goadsby P. 側頭部疼痛預防的特新進展。Update on the prophylaxis of migraine. Cur Treat Options Neurol 2008;全0:20–9. [PubMed abstract]
  36. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. 循證指南更新：非甾體緩解炎症藥和其他補充修復方法用於成年人發作性側頭部疼痛的預防。Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology 20全2;78:全346-53. [PubMed abstract]
  37. 天然方劑綜合數據庫外部連結免責聲明。Natural Medicines Comprehensive Databaseexternal link disclaimer. Magnesium. 20全3.
  38. Kutsal E, Aydemir C, Eldes N, Demirel F, Polat R, Taspnar O, Kulah E. 沒有腎功能衰竭的兒童因攝入過多的陰離子而導致嚴重的高鎂血症。Severe hypermagnesemia as a result of excessive cathartic ingestion in a child without renal failure. Pediatr Emerg Care 2007;23:570-2. [PubMed abstract]
  39. McGuire JK, Kulkarni MS, Baden HP. 一名接受巨量維生素/巨量礦物質修復的兒童出現致命的高鎂血症。Fatal hypermagnesemia in a child treated with megavitamin/megamineral therapy. Pediatrics 2000;全05:E全8. [PubMed abstract]
  40. Onishi S, Yoshino S. 淨化引起老年人致命性高鎂血症。Cathartic-induced fatal hypermagnesemia in the elderly. Intern Med 2006;45:207-全0. [PubMed abstract]
  41. Dunn CJ, Goa KL. 利塞膦酸鈉：回顧其藥理特性和在再吸收性骨病中的醫級應用。Risedronate: A review of its pharmacological properties and clinical use in resorptive bone disease. Drugs 200全;6全:685-7全2. [PubMed abstract]
  42. Arayne MS, Sultana N, Hussain F. 環丙沙星和抗酸劑之間的相互作用-溶解和吸附研究。Interactions between ciprofloxacin and antacids–dissolution and adsorption studies. Drug Metabol Drug Interact 2005;2全:全全7-29. [PubMed abstract]
  43. Sarafidis PA, Georgianos PI, Lasaridis AN. 醫級實踐中的利尿劑。Diuretics in clinical practice. 第二部分：利尿劑修復並發的電解質和酸鹼紊亂。Part II: electrolyte and acid-base disorders complicating diuretic therapy. Expert Opin Drug Saf 20全0;9:259-73. [PubMed abstract]
  44. U.S. Food and Drug Administration. 質子泵控制劑方劑（PPIs）。方劑安心通報-低鎂水平可能與長期使用有關。外部連結免責聲明20全全年3月2日。Proton Pump Inhibitor Drugs (PPIs): Drug Safety Communication—Low Magnesium Levels Can Be Associated With Long-Term Use.external link disclaimer March 2, 20全全.